ZCA1 tcrb-V (O1);june 4-5, 2018;DR. Eduardo emilio chufan;bethesda north hotel & conference center;total hotel cost complies with HHS policy on promoting efficient spending as of 1/3/2012
Ended Awarded Last action
- Contract number
- 75N91018F00086
- Awardee
-
Bsrep II MBN LLC UEI TRP2FSD3MF43 Part of Marriott International Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,964
Award facts
- Contract value 100% obligated
- $14,963.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 721110 Hotels (except Casino Hotels) and Motels
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,661 | |
| Original award | $20,625 |
About this award
The National Cancer Institute awarded a BPA (Blanket Purchase Agreement) call valued at $14,963.62 to Bsrep II MBN LLC, doing business as Bethesda North Marriott Hotel & Conference Center, on April 17, 2018. This firm fixed-price contract, which does not utilize a set-aside designation, was issued to support a conference event (ZCA1 TCRB-V) held June 4-5, 2018, at the Bethesda North Hotel & Conference Center in Bethesda, Maryland, with Dr. Eduardo Emilio Chufan as the listed point of contact. The hotel costs comply with HHS policy on promoting efficient spending as of January 3, 2012.
Bsrep II MBN LLC is a subsidiary of Marriott International Inc. and specializes in providing hospitality services to federal agencies, particularly those within the Department of Health and Human Services and the National Institutes of Health. The company maintains an extensive track record of supplying conference facilities, lodging, meeting rooms, and audiovisual equipment for scientific peer review meetings and government events. The contract ultimate completion date was set for March 3, 2023, and the award included a de-obligation of funds from FY2018 expiring lines in accordance with NIH Office of Administrative and Management Communications 23-18.
Quick answers
Who was awarded contract 75N91018F00086?
75N91018F00086 was awarded to Bsrep II MBN LLC by National Cancer Institute (National Institutes of Health) on April 17, 2018.
How much is contract 75N91018F00086 worth?
The government has obligated $14,964 on 75N91018F00086.
Is contract 75N91018F00086 an order under another contract?
Yes. 75N91018F00086 is a BPA call under HHSN263201500186B, a blanket purchase agreement.
Was contract 75N91018F00086 competed?
The extent of competition for 75N91018F00086 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award